RE:RE:RE:RE:RE:Did You Notice CC Abbott’s “Disclosures”?ilikethebible80 wrote:
33 I did not get any headup about the delay. I put 100% of my money here in Prometic, like many long here, thinking/hoping for an early decision (i.e. before the year end 2017). Because of Prometic, I missed one of my first picks (Antibe) that went from $0.09 to $0.25 while I was waiting for Plasminogen's approval. I sold my Prometic shares to get into Antibe @$0.25 and sold at $0.64 when they reported a positive data.
Best,
CC
Hey CC,
Firstly, I really do like the attention you bring to PLI on that large audience outlet, SA (since it has been positive, haha!)
I wasn't asking for nor were you obligated to lay out the exact details of your Buying and Selling.
But since you did, and out of curiosity, I went to take a look at Antibe (ATE) and noticed a few things about the chart and your story that don't quite line up. Most interesting is that there are only two days on which you could have sold at $0.64 cents. The 20th or 21st of March. You published this article:
Antibe: A Buy For Their GI-Safe Next-Generation NSAID Potential on SA on the 21st, so the SAME day or day AFTER you sold? What gives with that? Is that part of your Modus Operandi? Sell stock and then call the company a Buy? Or the other way around? You published at market open so were you hoping to drive the price as high as possible before you bailed?
Also, the first time ATE was at $0.25 cents was Jan. 30/18 so if you sold PLI in December - as you said in a response to another poster, I believe - you waited a month to buy a stock you wanted badly at $0.09 and were putting off buying and could have bought around $0.18 all through Jan?
Something doesn't quite wash.
Again, you're not obligated to explain or respond and I DO like your PLI articles. I just find the "I'm just altruistically giving my opinions with no guile and no ulterior motive" wearing a bit thin.
Sorry, but when I say I "stand corrected" and find I may not have been totally wrong... you know?
;-) 33